绘画联合药物干预对焦虑障碍患者的治疗效果

Clinical efficacy of painting combined with drug intervention in treating patients with anxiety disorder

  • 摘要:
    目的 观察绘画联用药物干预对焦虑障碍患者的治疗效果。
    方法 将83例焦虑障碍患者随机分为对照组(n=41)和试验组(n=42)。对照组采取常规药物治疗,试验组在药物治疗基础上联合绘画疗法。比较2组患者简易生存质量量表(SF-36)评分、WHO生活质量简表(WHOQOL-BREF)评分、治疗依从率、心理状态汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)评分以及血清脑源性神经营养因子(BDNF)、超氧化物歧化酶(SOD)和丙二醛(MDA)水平。
    结果 治疗后,试验组SF-36评分为(83.12±5.11)分,高于对照组的(71.32±5.48)分,差异有统计学意义(P < 0.05)。治疗后, 2组WHOQOL-BREF各项评分及总分均提高,且试验组评分高于对照组,差异有统计学意义(P < 0.05)。治疗后, 2组HAMA、HAMD评分均下降,且试验组HAMA、HAMD评分低于对照组,差异有统计学意义(P < 0.05)。对照组治疗依从率为58.54%, 低于试验组的88.10%, 差异有统计学意义(P < 0.05)。治疗后,试验组BDNF、MDA水平低于对照组, SOD水平高于对照组,差异有统计学意义(P < 0.05)。
    结论 绘画联合药物干预可有效改善焦虑障碍患者的焦虑症状,提高治疗依从率和生活质量。

     

    Abstract:
    Objective To observe the therapeutic effect of painting combined with drug intervention in treatment of patients with anxiety disorder.
    Methods A total of 83 patients with anxiety disorder were randomly divided into control group (n=41) and trail group (n=42). The control group was treated with conventional drugs, while the trail group was treated with painting therapy on the basis of drug therapy. The score of the 36-item Short-form Health Survey (SF-36), the Brief Scale of WHO Quality of Life (WHOQOL-BREF), therapeutic compliance rate, psychological statusthe Hamilton Depression Scale (HAMD) and the Hamilton Anxiety Scale (HAMA) scores and levels of serum brain derived neurotrophic factor (BDNF), superoxide dismutase (SOD) and malondialdehyde (MDA) were compared between the two groups.
    Results After treatment, the SF-36 score in the trail group was (83.12±5.11), which was significantly higher than (71.32±5.48) in the control group (P < 0.05). After treatment, score of each item and the total score of WHOQOL-BREF in both groups increased significantly, and the scores in the trail group were significantly higher than those in the control group (P < 0.05). After treatment, the scores of HAMA and HAMD in both groups decreased significantly, and the scores of HAMA and HAMD in the trail group were significantly lower than those in the control group (P < 0.05). The therapeutic compliance rate of the control group was 58.54%, which was significantly lower than 88.10% of the trail group (P < 0.05). After treatment, the levels of BDNF and MDA in the trail group were significantly lower than those in the control group, while the level of SOD was significantly higher than that in the control group (P < 0.05).
    Conclusion Painting combined with drug intervention can effectively improve the anxiety symptoms of patients with anxiety disorder and enhance the therapeutic compliance rate and quality of life.

     

/

返回文章
返回